Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-07

Clinical Trial Update: Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant [Phase 3]

View source ↗

Summary

Phase 3 trial comparing caspofungin acetate, fluconazole, and voriconazole for preventing fungal infections in patients after donor hematopoietic stem cell tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caspofungin Acetate (caspofungin acetate)
  • Fluconazole (Fluconazole)
  • VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Children's Oncology Group | Conditions: Fungal Infection, Hematopoietic and Lymphoid Cell Neoplasm | Phase 3 | Status: COMPLETED | Results posted: 2021-01-07